Skip to content

Clinical trials

Phase 3 Autoimmune Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 3 Country / region: Germany Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20082
20092
20102
20111
20121
20131
20151
20211
20222
20234
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting5
Active, not recruiting3
Enrolling by invitation1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Human Genome Sciences Inc., a GSK Company4
Immunovant Sciences GmbH3
Viatris Innovation GmbH2
Amgen1
AstraZeneca1
Baxalta now part of Shire1
Bristol-Myers Squibb1
Diamyd Medical AB1
Eli Lilly and Company1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases25
Immune System Diseases9
Lupus Erythematosus, Systemic9
Connective Tissue Diseases6
Arthritis, Rheumatoid3
Arthritis2
Graves Ophthalmopathy2
Joint Diseases2
Lung Diseases, Interstitial2
Lupus Nephritis2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.